MENU
+Compare
GKOS
Stock ticker: NYSE
AS OF
Aug 11, 04:59 PM (EDT)
Price
$86.99
Change
+$2.34 (+2.76%)
Capitalization
4.85B

GKOS Glaukos Corp Forecast, Technical & Fundamental Analysis

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases... Show more

GKOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for GKOS with price predictions
Aug 08, 2025

GKOS's RSI Indicator is sitting in oversold zone for 1 day

It is expected that a price bounce should occur soon.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where GKOS advanced for three days, in of 328 cases, the price rose further within the following month. The odds of a continued upward trend are .

GKOS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on July 15, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on GKOS as a result. In of 96 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for GKOS turned negative on July 15, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 57 similar instances when the indicator turned negative. In of the 57 cases the stock turned lower in the days that followed. This puts the odds of success at .

GKOS moved below its 50-day moving average on July 21, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for GKOS crossed bearishly below the 50-day moving average on July 25, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where GKOS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for GKOS entered a downward trend on August 08, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock slightly better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. GKOS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.345) is normal, around the industry mean (57.379). P/E Ratio (0.000) is within average values for comparable stocks, (37.765). GKOS's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.644). GKOS has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.020). P/S Ratio (10.977) is also within normal values, averaging (90.474).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

View a ticker or compare two or three
GKOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

GKOS is expected to report earnings to rise 3.38% to -24 cents per share on October 29

Glaukos Corp GKOS Stock Earnings Reports
Q3'25
Est.
$-0.25
Q2'25
Beat
by $0.02
Q1'25
Beat
by $0.13
Q4'24
Missed
by $0.02
Q3'24
Beat
by $0.20
The last earnings report on July 30 showed earnings per share of -23 cents, beating the estimate of -25 cents. With 219.88K shares outstanding, the current market capitalization sits at 4.85B.
A.I. Advisor
published General Information

General Information

an ophthalmic medical device company

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
One Glaukos Way
Phone
+1 949 367-9600
Employees
907
Web
https://www.glaukos.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CTHRX108.310.81
+0.75%
Columbia Global Technology Growth Inst2
IGIUX105.920.56
+0.53%
Integrity Growth & Income Fund C
GMYPX17.310.08
+0.46%
Goldman Sachs Large Cap Value P
BGEIX20.620.07
+0.34%
American Century Global Gold Inv
IFAFX26.750.07
+0.26%
American Funds Income Fund of Amer F1

GKOS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, GKOS has been loosely correlated with ISRG. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if GKOS jumps, then ISRG could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GKOS
1D Price
Change %
GKOS100%
-3.81%
ISRG - GKOS
51%
Loosely correlated
-0.84%
ITGR - GKOS
50%
Loosely correlated
+0.69%
NTRA - GKOS
48%
Loosely correlated
+7.70%
RDNT - GKOS
47%
Loosely correlated
+1.58%
DXCM - GKOS
46%
Loosely correlated
+3.22%
More

Groups containing GKOS

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GKOS
1D Price
Change %
GKOS100%
-3.81%
Medical/Nursing Services
industry (227 stocks)
55%
Loosely correlated
+0.31%
Health Services
industry (442 stocks)
34%
Loosely correlated
+0.88%